Transsphenoidal surgery for pituitary tumours: frequency and predictors of delayed hyponatraemia and their relationship to early readmission

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Transsphenoidal surgery for pituitary tumours : frequency and predictors of delayed hyponatraemia and their relationship to early readmission. / Krogh, Jesper; Kistorp, Caroline N; Jafar-Mohammadi, Bahram; Pal, Aparna; Cudlip, Simon; Grossman, Ashley.

I: European Journal of Endocrinology, Bind 178, Nr. 3, 2018, s. 247-253.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Krogh, J, Kistorp, CN, Jafar-Mohammadi, B, Pal, A, Cudlip, S & Grossman, A 2018, 'Transsphenoidal surgery for pituitary tumours: frequency and predictors of delayed hyponatraemia and their relationship to early readmission', European Journal of Endocrinology, bind 178, nr. 3, s. 247-253. https://doi.org/10.1530/EJE-17-0879

APA

Krogh, J., Kistorp, C. N., Jafar-Mohammadi, B., Pal, A., Cudlip, S., & Grossman, A. (2018). Transsphenoidal surgery for pituitary tumours: frequency and predictors of delayed hyponatraemia and their relationship to early readmission. European Journal of Endocrinology, 178(3), 247-253. https://doi.org/10.1530/EJE-17-0879

Vancouver

Krogh J, Kistorp CN, Jafar-Mohammadi B, Pal A, Cudlip S, Grossman A. Transsphenoidal surgery for pituitary tumours: frequency and predictors of delayed hyponatraemia and their relationship to early readmission. European Journal of Endocrinology. 2018;178(3):247-253. https://doi.org/10.1530/EJE-17-0879

Author

Krogh, Jesper ; Kistorp, Caroline N ; Jafar-Mohammadi, Bahram ; Pal, Aparna ; Cudlip, Simon ; Grossman, Ashley. / Transsphenoidal surgery for pituitary tumours : frequency and predictors of delayed hyponatraemia and their relationship to early readmission. I: European Journal of Endocrinology. 2018 ; Bind 178, Nr. 3. s. 247-253.

Bibtex

@article{ca1fa0142aba45bb8370d2dd48008287,
title = "Transsphenoidal surgery for pituitary tumours: frequency and predictors of delayed hyponatraemia and their relationship to early readmission",
abstract = "OBJECTIVE: A major cause of readmission after transsphenoidal surgery (TSS) is delayed hyponatraemia. The purpose of this study was to identify predictors of hyponatraemia one week post surgery and predictors of 30-day readmissions for hyponatraemia.DESIGN: A retrospective cohort study including patients who had TSS performed for pituitary lesions.METHOD: The risk of readmission for hyponatraemia was assessed in consecutive patients between January 2008 and March 2016. The risk of hyponatraemia one week post surgery was assessed in patients admitted for TSS between July 2011 and March 2016.RESULTS: Of all included patients, 56/522 (10.7%) were readmitted within 30 days. Hyponatraemia was found in 14/56 (25%) of 30-day readmissions. We did not identify any predictive variable for hyponatraemia on readmission. The number of patients with hyponatraemia on the seventh post-operative day was 26/314 (8.3%). The risk of hyponatraemia one week post surgery was increased by an odds ratio of 2.40 (95% CI: 1.06-5.40) in patients with a tumour abutting the optic chiasm and by an odds ratio of 1.16 (1.04-1.31) per mmol/L decrease in sodium levels on the first post-operative day.CONCLUSIONS: Hyponatraemia occurred in 25% of readmissions; however, we did not identify any predictive variable for readmission with hyponatraemia. One week post surgery, 8.9% had hyponatraemia. Tumours pressing on the optic chiasm as well as a fall in sodium levels on the first post-operative day were associated with an increased risk of hyponatraemia one week post surgery. We suggest that a day 7 serum sodium <130 nmol/L should lead to concern and the provision of patient advice.",
keywords = "Adenoma/surgery, Adult, Aged, Cohort Studies, Female, Humans, Hyponatremia/epidemiology, Logistic Models, Male, Middle Aged, Multivariate Analysis, Neurosurgical Procedures, Patient Readmission/statistics & numerical data, Pituitary Neoplasms/surgery, Postoperative Complications/epidemiology, Retrospective Studies, Sphenoid Bone, Sphenoid Sinus",
author = "Jesper Krogh and Kistorp, {Caroline N} and Bahram Jafar-Mohammadi and Aparna Pal and Simon Cudlip and Ashley Grossman",
note = "{\textcopyright} 2018 European Society of Endocrinology.",
year = "2018",
doi = "10.1530/EJE-17-0879",
language = "English",
volume = "178",
pages = "247--253",
journal = "Acta Endocrinologica, Supplement",
issn = "0804-4635",
publisher = "BioScientifica Ltd.",
number = "3",

}

RIS

TY - JOUR

T1 - Transsphenoidal surgery for pituitary tumours

T2 - frequency and predictors of delayed hyponatraemia and their relationship to early readmission

AU - Krogh, Jesper

AU - Kistorp, Caroline N

AU - Jafar-Mohammadi, Bahram

AU - Pal, Aparna

AU - Cudlip, Simon

AU - Grossman, Ashley

N1 - © 2018 European Society of Endocrinology.

PY - 2018

Y1 - 2018

N2 - OBJECTIVE: A major cause of readmission after transsphenoidal surgery (TSS) is delayed hyponatraemia. The purpose of this study was to identify predictors of hyponatraemia one week post surgery and predictors of 30-day readmissions for hyponatraemia.DESIGN: A retrospective cohort study including patients who had TSS performed for pituitary lesions.METHOD: The risk of readmission for hyponatraemia was assessed in consecutive patients between January 2008 and March 2016. The risk of hyponatraemia one week post surgery was assessed in patients admitted for TSS between July 2011 and March 2016.RESULTS: Of all included patients, 56/522 (10.7%) were readmitted within 30 days. Hyponatraemia was found in 14/56 (25%) of 30-day readmissions. We did not identify any predictive variable for hyponatraemia on readmission. The number of patients with hyponatraemia on the seventh post-operative day was 26/314 (8.3%). The risk of hyponatraemia one week post surgery was increased by an odds ratio of 2.40 (95% CI: 1.06-5.40) in patients with a tumour abutting the optic chiasm and by an odds ratio of 1.16 (1.04-1.31) per mmol/L decrease in sodium levels on the first post-operative day.CONCLUSIONS: Hyponatraemia occurred in 25% of readmissions; however, we did not identify any predictive variable for readmission with hyponatraemia. One week post surgery, 8.9% had hyponatraemia. Tumours pressing on the optic chiasm as well as a fall in sodium levels on the first post-operative day were associated with an increased risk of hyponatraemia one week post surgery. We suggest that a day 7 serum sodium <130 nmol/L should lead to concern and the provision of patient advice.

AB - OBJECTIVE: A major cause of readmission after transsphenoidal surgery (TSS) is delayed hyponatraemia. The purpose of this study was to identify predictors of hyponatraemia one week post surgery and predictors of 30-day readmissions for hyponatraemia.DESIGN: A retrospective cohort study including patients who had TSS performed for pituitary lesions.METHOD: The risk of readmission for hyponatraemia was assessed in consecutive patients between January 2008 and March 2016. The risk of hyponatraemia one week post surgery was assessed in patients admitted for TSS between July 2011 and March 2016.RESULTS: Of all included patients, 56/522 (10.7%) were readmitted within 30 days. Hyponatraemia was found in 14/56 (25%) of 30-day readmissions. We did not identify any predictive variable for hyponatraemia on readmission. The number of patients with hyponatraemia on the seventh post-operative day was 26/314 (8.3%). The risk of hyponatraemia one week post surgery was increased by an odds ratio of 2.40 (95% CI: 1.06-5.40) in patients with a tumour abutting the optic chiasm and by an odds ratio of 1.16 (1.04-1.31) per mmol/L decrease in sodium levels on the first post-operative day.CONCLUSIONS: Hyponatraemia occurred in 25% of readmissions; however, we did not identify any predictive variable for readmission with hyponatraemia. One week post surgery, 8.9% had hyponatraemia. Tumours pressing on the optic chiasm as well as a fall in sodium levels on the first post-operative day were associated with an increased risk of hyponatraemia one week post surgery. We suggest that a day 7 serum sodium <130 nmol/L should lead to concern and the provision of patient advice.

KW - Adenoma/surgery

KW - Adult

KW - Aged

KW - Cohort Studies

KW - Female

KW - Humans

KW - Hyponatremia/epidemiology

KW - Logistic Models

KW - Male

KW - Middle Aged

KW - Multivariate Analysis

KW - Neurosurgical Procedures

KW - Patient Readmission/statistics & numerical data

KW - Pituitary Neoplasms/surgery

KW - Postoperative Complications/epidemiology

KW - Retrospective Studies

KW - Sphenoid Bone

KW - Sphenoid Sinus

U2 - 10.1530/EJE-17-0879

DO - 10.1530/EJE-17-0879

M3 - Journal article

C2 - 29263154

VL - 178

SP - 247

EP - 253

JO - Acta Endocrinologica, Supplement

JF - Acta Endocrinologica, Supplement

SN - 0804-4635

IS - 3

ER -

ID: 217657500